Last reviewed · How we verify
Keytruda — cost & pricing
Pembrolizumab blocks PD-1 receptor, releasing immune inhibition and enhancing anti-tumor T-cell response.
Pricing
| Country | Currency | Price | Annual cost (USD) |
|---|---|---|---|
Commercial
Annual revenue: 29500.
See also
- Full profile: Keytruda
- Side effects: /side-effects
- Dosage & administration: /dosage
- Mechanism of action: /mechanism
- Drug interactions: /interactions
- Clinical trials: /clinical-trials
- Patents & exclusivity: /patents
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing